Oct 23, 2026 04:04PM
Oct 23, 2026 04:01PM
Oct 5, 2026 08:01AM
Oct 5, 2026 08:01AM
May 7, 2026 08:02AM
May 7, 2026 08:01AM
Apr 27, 2026 08:01AM Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings
Mar 9, 2026 04:05PM
Feb 19, 2026 04:01PM
Feb 3, 2026 08:29AM
Feb 3, 2026 08:29AM
Jan 23, 2026 12:56PM
Jan 9, 2026 03:20AM
Nov 7, 2025 04:05PM Ardelyx presents real-world data on XPHOZAH at kidney conference
Nov 7, 2025 04:05PM
Oct 30, 2025 04:01PM
Oct 28, 2025 08:02AM
Oct 28, 2025 08:01AM
Oct 21, 2025 08:00AM
May 6, 2025 08:02AM
May 6, 2025 08:01AM Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference
Apr 24, 2025 08:01AM
Apr 10, 2025 04:03PM
Apr 10, 2025 04:02PM
Mar 31, 2025 04:04PM
Mar 31, 2025 04:03PM
Feb 20, 2025 07:30AM
Nov 8, 2024 12:34PM Ardelyx (ARDX) Responds to District Court Decision Granting Motion to Dismiss
Nov 8, 2024 12:31PM
Nov 8, 2024 12:31PM
Oct 24, 2024 04:06PM
Oct 24, 2024 04:05PM
Oct 15, 2024 08:00AM
Oct 9, 2024 08:05AM
Oct 9, 2024 08:05AM Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
Jul 31, 2024 08:02AM
Jul 17, 2024 05:10PM
May 21, 2024 08:02AM
May 16, 2024 08:01AM
May 7, 2024 08:01AM
May 2, 2024 04:02PM
May 1, 2024 08:00AM Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
Feb 22, 2024 04:01PM
Jan 8, 2024 08:05AM
Jan 8, 2024 08:00AM
Jan 3, 2024 08:03AM
Nov 15, 2023 04:02PM
Nov 15, 2023 04:02PM
Nov 13, 2023 04:03PM Ardelyx (ARDX) Announces Resignation of Geoffrey Block from Board
Nov 13, 2023 04:02PM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All